Deepdive_logo

Changing steps: Rewriting the rules of the biologics patent dance

_____

With several blockbuster biologics set to lose exclusivity in the US by 2030, biosimilars are preparing to make their move. But, in order to make it to market, they must first master the complex choreography of “the patent dance”

April 2024: Market Access

Read article

Featured article:
Rare diseases: the urgent need for health equity and accelerated access

Read article

Featured:
Overcoming AMR market failure: Three start-up stories

 

Read article

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Send